Skip to main content
SpringerLink
Log in

Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Psychotropic Drugs

  • Review Article
  • Pharmacoepidemiology
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The use of psychotropic drugs has been associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in a number of case reports. SIADH is characterised by the sustained release of antidiuretic hormone (ADH) from the posterior pituitary. The patients have a reduced ability to excrete diluted urine, ingested fluid is retained, and the extracellular fluid expands and becomes hypo-osmolar. The cardinal signs are hyponatraemia, serum hypoosmolality and a less than maximally diluted urine. Common symptoms include weakness, lethargy, headache, anorexia and weight gain. These symptoms may be followed by confusion, convulsions, coma and death. The early symptoms are vague and nonspecific, and they may even mimic the symptoms of the psychiatric disorder itself.

For antidepressants, the risk of SIADH seems to be highest during the first weeks of treatment. For antipsychotics, the risk seems to be more spread out in time. The causative role of the drug may sometimes be difficult to estimate, as even drug-free psychiatric patients, mostly those with schizophrenia, develop SIADH on the basis of psychogenic polydipsia. Smoking is another factor associated with the development of SIADH, and the risk may also increase with age.

The acute treatment of SIADH induced by a psychotropic drug includes discontinuation of the drug as well as restriction of fluid intake. In cases with significant clinical symptoms, infusion of sodium chloride is recommended. After the acute management, it is useful to evaluate the causative role of the drug by performing a water loading test and/or drug rechallenge. If continued treatment with an antidepressant or antipsychotic is indicated, a drug with a different pharmacological profile should be chosen, and the serum sodium levels should be monitored closely. If treatment with the drug that caused SIADH must be continued, concomitant treatment with demeclocycline may reduce the tendency of hyponatraemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Culpepper RM, Hébert SC, Andreoli TE. The posterior pituitary and water metabolism. In: Wilson JD, Foster DW, editors. Williams textbook of endocrinology. 7th ed. Philadelphia: WB Saunders, 1985: 614–52

    Google Scholar 

  2. Hays RM. Agents affecting the renal conservation of water. In: Gilman AG, Rall TW, Nies AS, et al., editors. Goodman and Gilmans’s the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 632–42

    Google Scholar 

  3. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967; 42: 790–806

    PubMed  CAS  Google Scholar 

  4. Kowacs L, Robertson GL. Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992; 21: 859–75

    Google Scholar 

  5. Crammer JL. Drinking, thirst and water intoxication. Br J Psychiatry 1991; 159: 83–9

    PubMed  CAS  Google Scholar 

  6. Miller M, Moses AM. Drug-induced states of impaired water excretion. Kidney Int 1976; 10: 96–103

    PubMed  CAS  Google Scholar 

  7. Sandifer MG. Hyponatremia due to psychotropic drugs. J Clin Psychiatry 1983; 44: 301–3

    PubMed  CAS  Google Scholar 

  8. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145: 675–83

    PubMed  CAS  Google Scholar 

  9. Leibowitz SF, Eidelman D, Suh JS, et al. Mapping study of noradrenergic stimulation of vasopressin release. Exp Neurol 1990; 110: 298–305

    PubMed  CAS  Google Scholar 

  10. Leibowitz SF, Jhanwar-Uniyal M, Dvorkin B, et al. Distribution of α-adrenergic, β-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res 1982; 233: 97–114

    PubMed  CAS  Google Scholar 

  11. Ivoino M, Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 1985; 113: 99–103

    Google Scholar 

  12. Brownfield MS, Greathouse J, Lorens SA, et al. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinol 1988; 47: 277–83

    CAS  Google Scholar 

  13. Anderson IK, Martin GR, Ramage AG. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexication and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. BrJ Pharmacol 1992; 107: 1020–8

    CAS  Google Scholar 

  14. Pérgola PE, Sved AF, Voogt JL, et al. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 1993; 57: 550–8

    PubMed  Google Scholar 

  15. Yamaguchi K, Hama H. Facilatory role of central dopamine in the osmotic release of vasopressin. Brain Res 1989; 481: 388–91

    PubMed  CAS  Google Scholar 

  16. Yamaguchi K, Hama H, Adachi C. Inhibitory role of periventricular dopaminergic mechanisms in hemorrhage-induced vasopressin secretion in conscious rats. Brain Res 1990; 513: 335–8

    PubMed  CAS  Google Scholar 

  17. Holzbauer M, Racké K. The dopaminergic innervation of the intermediate lobe and of the neural lobe of the pituitary gland. MedBiol 1985; 63: 97–116

    CAS  Google Scholar 

  18. Wells T, Forsling ML. Aminergic control of vasopressin secretion in the conscious rat. J Physiol Pharmacol 1992; 43: 57–61

    Google Scholar 

  19. Kendler KS, Weitzman RE, Rubin RT. Lack of arginine vasopressin response to central dopamine blockade in normal adults. J Clin Endocrinol Metabolism 1978; 47: 204–7

    CAS  Google Scholar 

  20. Raskind MA, Courtney N, Murburg MM, et al. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. Biol Psychiatry 1987; 22: 453–62

    PubMed  CAS  Google Scholar 

  21. Sarai M, Matsunaga H. ADH secretion in schizophrenic patients on antipsychotic drugs. Biol Psychiatry 1989; 26: 576–80

    PubMed  CAS  Google Scholar 

  22. Water homeostasis in psychiatric inpatients [editorial]. Biol Psychiatry 1987; 22: 121-5

    Google Scholar 

  23. Zabik JE, Sprague JE, Odio M. Interactive dopaminergic and noradrenergic systems in the regulation of thirst in the rat. Physiol Behav 1993; 54: 29–33

    PubMed  CAS  Google Scholar 

  24. Hubbard JI, Lin N, Sibbald JR. Subfornicai organ lesions in rats abolish hyperdipsic effects of isoproterenol and serotonin. Brain Res Bull 1989; 23: 41–5

    PubMed  CAS  Google Scholar 

  25. Lawson WB, Karson CN, Bigelow LB. Increased urine volume in chronic schizophrenic patients. Psychiatry Res 1985; 14: 323–31

    PubMed  CAS  Google Scholar 

  26. Verghese C, de Leon J, Simpson GM. Neuroendocrine factors influencing polydipsia in psychiatric patients: an hypothesis. Neuropsychopharmacology 1993; 9: 157–66

    PubMed  CAS  Google Scholar 

  27. Lee HS, Kwon KY, Alphs LD. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia. J Clin Psychopharmacol 1991; 11: 222–3

    PubMed  CAS  Google Scholar 

  28. Munn NA. Resolution of polydipsia and hyponatremia in schizophrenic patients after clozapine treatment. J Clin Psychiatry 1993; 54: 439–40

    PubMed  CAS  Google Scholar 

  29. Kovacs K, Kovacs GS, Kovacs BM, et al. The effect of chlorpromazine on the activity of the antidiuretic hormone. Arch Int Pharmacodyn 1957; 109: 1–7

    PubMed  CAS  Google Scholar 

  30. Torvey WP. Mechanisms of carbamazepine-induced antidiuresis [letter]. J Neurol Neurosurg Psychiatry 1993; 56: 567

    Google Scholar 

  31. de Leon J, Verghese C, Tracy JI, et al. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994; 35: 408–19

    PubMed  Google Scholar 

  32. Kimelman N, Albert SG. Phenothiazine-induced hyponatremia in the elderly. Gerontology 1984; 30: 132–6

    PubMed  CAS  Google Scholar 

  33. Kazal LA, Hall DL, Miller LG, et al. Fluoxetine-induced SIADH: a geriatric occurrence? J Fam Pract 1993; 36: 341–3

    PubMed  Google Scholar 

  34. Raskind MA, Orenstein H, Christopher TG. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. Am J Psychiatry 1975; 132: 907–10

    PubMed  CAS  Google Scholar 

  35. Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry 1979; 136: 221–2

    PubMed  CAS  Google Scholar 

  36. Blum A. The possible role of tobacco cigarette smoking in hyponatremia of long-term psychiatric patients. JAMA 1984; 252: 2864–5

    PubMed  CAS  Google Scholar 

  37. Rosenbaum JF, Rothman JS, Murray GB. Psychosis and water intoxication. J Clin Psychiatry 1979; 40: 287–91

    PubMed  CAS  Google Scholar 

  38. Wetterling T. Hyponatremie — unterschätzte Komplikation beipsychiatrischen Patienten. Nervenarzt 1987; 58: 625–31

    PubMed  CAS  Google Scholar 

  39. Khamnei AK. Psychosis, inappropriate antidiuretic hormone secretion, and water intoxication [letter]. Lancet 1984; 1: 963

    PubMed  CAS  Google Scholar 

  40. Raskind MA, Weitzman RE, Orenstein H, et al. Is antidiuretic hormone elevated in psychosis? A pilot study. Biol Psychiatry 1978; 13: 385–90

    PubMed  CAS  Google Scholar 

  41. Husain MK, Fernando N, Shapiro M, et al. Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab 1973; 37: 616–25

    PubMed  CAS  Google Scholar 

  42. Kirch DG, Bigelow LB, Weinberger DR, et al. Polydipsia and chronic hyponatremia in schizophrenic inpatients. J Clin Psychiatry 1985; 46: 179–81

    PubMed  CAS  Google Scholar 

  43. Ellinas PA, Rosner F, Jaume JC. Symptomatic hyponatremi associated with psychosis, medications, and smoking. J Nati Med Assoc 1993; 85: 135–40

    CAS  Google Scholar 

  44. Vieweg V, Rowe W, David J, et al. Hyposthenuria as a marker for self-induced water intoxication and schizophrenic disorders. Am J Psychiatry 1984; 141: 1258–60

    PubMed  CAS  Google Scholar 

  45. Vieweg WVR, Rowe WT, David JJ, et al. Evaluation of patients with self-induced water intoxication and schizophrenic disorders (SIWIS). J Nerv Ment Dis 1984; 172: 552–5

    PubMed  CAS  Google Scholar 

  46. Jose CJ, Evenson R. Antecedents of self-induced water intoxication. A preliminary report. J Nerv Ment Dis 1980; 168: 498–500

    PubMed  CAS  Google Scholar 

  47. Weitzel WD, Shraberg D, Work J. Inappropriate ADH secretion: the role of drug re-challenge. Psychosomatics 1980; 21: 771–9

    PubMed  CAS  Google Scholar 

  48. de Rivera JLG. Inappropriate secretion of antidiuretic hormone from fluphenazine therapy. Ann Intern Med 1975; 82: 811–2

    PubMed  Google Scholar 

  49. Cordoba OA, Chapel JL. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) secondary to antipsychotic drug therapy. Mo Med 1978; 75: 177–8

    PubMed  CAS  Google Scholar 

  50. Kennedy MJ, Shelley RK, Daly PA. Potentiation of small cell lung cancer-related SIADH by trifluoperazine. Eur J Respir Dis 1987; 71: 450–4

    PubMed  CAS  Google Scholar 

  51. Hamburger S, Langley H, Bowers G. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline or trifluoperazine administration [letter]. J Kans Med Soc 1980; 81: 469–70

    PubMed  CAS  Google Scholar 

  52. Vincent FM, Emery S. Antidiuretic hormone syndrome and thioridazine [letter]. Ann Intern Med 1978; 89: 147–8

    PubMed  CAS  Google Scholar 

  53. Caron C, Shooner K, Martineau M, et al. Water intoxication in a schizophrenic patient under treatment with thioridazine: study of the physiopathological mechanisms involved [in French]. Ls’union Med Can 1979; 108: 1078–82

    CAS  Google Scholar 

  54. Matuk F, Kalyanaraman K. Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs. Arch Neurol 1977; 34: 374–5

    PubMed  CAS  Google Scholar 

  55. Glusac E, Patel H, Josef NC, et al. Polydipsia and hyponatremia induced by multiple neuroleptics but not molindone. Can J Psychiatry 1990; 35: 268–9

    PubMed  CAS  Google Scholar 

  56. Rao KJ, Miller M, Moses A. Water intoxication and thioridazine [letter]. Ann Intern Med 1975; 82: 61

    PubMed  CAS  Google Scholar 

  57. Fishman CM. Water intoxication and thioridazine [letter]. Ann Intern Med 1975; 82: 852

    Google Scholar 

  58. Ananth J, Lin K-M. SIADH: a serious side effect of psychotropic drugs. Int Psychiatry Med 1986—87; 16(4): 401–7

    Google Scholar 

  59. Ajlouni K, Kern MW, Tures JF, et al. Thiothixene-induced hyponatremia. Ann Intern Med 1974; 134: 1103–5

    CAS  Google Scholar 

  60. Peck V, Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther 1979; 26: 442–4

    PubMed  CAS  Google Scholar 

  61. Kramer DS, Drake ME. Assessment of SIADH in psychosis with a water-loading test: case report. J Clin Psychiatry 1984; 45: 40–1

    PubMed  CAS  Google Scholar 

  62. Ogilvie AD, Croy MF. Clozapine and hyponatremia [letter]. Lancet 1992; 340: 672

    PubMed  CAS  Google Scholar 

  63. Wedzicha JA, Hoffbrand BI. Neuroleptic malignant syndrome and hyponatremia [letter]. Lancet 1984; 1: 963

    PubMed  CAS  Google Scholar 

  64. Tomson CRV. Neuroleptic malignant syndrome associated with inappropriate antidiuresis and psychogenic polydipsia. BMJ 1986; 292: 171

    PubMed  CAS  Google Scholar 

  65. Liskin B, Walsh BT, Roose SP. Imipramine-induced inappropriate ADH secretion. J Clin Psychopharmacol 1984; 4: 146–7

    PubMed  CAS  Google Scholar 

  66. Parker WA. Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion. DICP 1984; 18: 890–4

    CAS  Google Scholar 

  67. Mitsch RA, Lee AK. Syndrome of inappropriate antidiuretic hormone with imipramine. DICP 1986; 20: 787–9

    CAS  Google Scholar 

  68. Bozzolo M, Noll G, Luscher TF. Clinical-pharmacological case report: Drug-induced hypersecretion of ADH [in German]. Schweiz Rundsch Med Prax 1992; 81: 1435–8

    PubMed  CAS  Google Scholar 

  69. Madhusoodanan S, Onsos R. Amitriptyline induced hyponatraemia: a case report. Mt Sinai J Med 1981; 48: 431–3

    PubMed  CAS  Google Scholar 

  70. Luzecky MH, Burman KD, Schultz ER. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J 1974; 67: 495–7

    PubMed  CAS  Google Scholar 

  71. Solammadevi SV. Inappropriate antidiuresis during amitriptyline therapy [letter]. South Med J 1981; 74: 775–6

    PubMed  CAS  Google Scholar 

  72. Beckstrom D, Reding R, Cerletty J. Syndrome of inappropriate antidiuretic hormone secretion associated with amitriptyline administration [letter]. JAMA 1979; 241: 133

    PubMed  CAS  Google Scholar 

  73. Jensen M, Schambelan M. Inappropriate antidiuretic hormonsecretion. West J Med 1975; 122: 145–9

    Google Scholar 

  74. Gipson WT, Price TRP. Inappropriate ADH secretion in a psychiatric setting. Psychiatr Opin 1978; 115: 93–6

    Google Scholar 

  75. Hankin Y, Kaplan Z, Alkan M. Psychiatric presentation of hyponatremia associated with the use of amitriptyline — a report of two cases. Isr J Med Sci 1989; 25: 587–9

    Google Scholar 

  76. Garson M. Syndrome of dilutional hyponatraemia secondary to tricyclic antidepressant. Practitioner 1979; 222: 411–2

    PubMed  CAS  Google Scholar 

  77. Pledger DR, Mathew H. Hyponatraemia and clomipramine therapy. Br J Psychiatry 1989; 154: 263–4

    PubMed  CAS  Google Scholar 

  78. Zubenko GS, Altesman RI, Cassidy JW, et al. Disturbances of thirst and water homeostasis in patients with affective illness. Am J Psychiatry 1984; 141: 436–7

    PubMed  CAS  Google Scholar 

  79. Dahr SK, Ramos RR. Inappropriate antidiuresis during desipramine [letter]. Arch Intern Med 1978; 138: 1750–1

    Google Scholar 

  80. Lydiard RB. Desipramine-associated SIADH in an elderly woman: case report. J Clin Psychiatry 1983; 44: 153–4

    PubMed  CAS  Google Scholar 

  81. Os’Sullivan D, Oyebode F. Hyponatraemia and lofepramine [letter]. Br J Psychiatry 1987; 150: 720–1

    Google Scholar 

  82. Wylie KR, Harris SJ, Harrop FM. Lofepramine-induced hyponatraemia [letter]. Br J Psychiatry 1989; 154: 419–20

    PubMed  CAS  Google Scholar 

  83. Abbott R. Hyponatremia due to antidepressant medications. Ann Emerg Med 1983; 12: 708–10

    PubMed  CAS  Google Scholar 

  84. Fort S, Bannister P, Manning A, et al. Inappropriate antidiuretic secretion associated with dothiepin [letter]. Lancet 1985; 2: 551

    PubMed  CAS  Google Scholar 

  85. Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine [letter]. Am J Psychiatry 1989; 146: 399

    PubMed  CAS  Google Scholar 

  86. Gommans JH, Edwards RA. Fluoxetine and hyponatraemia [letter]. N Z Med J 1990; 103: 106

    PubMed  CAS  Google Scholar 

  87. Cohen BJ, Mahelsky M, Adler L. More cases of SIADH with fluoxetine [letter]. Am J Psychiatry 1990; 147: 948–9

    PubMed  CAS  Google Scholar 

  88. Staab JP, Yerkes SA, Cheney EM, et al. Transient SIADH associated with fluoxetine [letter]. Am J Psychiatry 1990; 147: 1569–70

    PubMed  CAS  Google Scholar 

  89. Marik PE, van Heerden W, Steenkamp V. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone excretion [letter]. S Afr Med J 1990; 78: 760–1

    PubMed  CAS  Google Scholar 

  90. Vishwanath BM, Navalgund AA, Cusano W, et al. Fluoxetine as a cause of SIADH [letter]. Am J Psychiatry 1991; 148: 542–3

    PubMed  CAS  Google Scholar 

  91. Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Ann Pharmacother 1993; 27: 723–4

    PubMed  CAS  Google Scholar 

  92. Goddard C, Paton C. Hyponatraemia associated with paroxetine. BMJ 1992; 305: 1332

    PubMed  CAS  Google Scholar 

  93. Chua TP, Vong SK. Hyponatraemia associated with paroxetine [letter]. BMJ 1993; 306: 143

    PubMed  CAS  Google Scholar 

  94. McHardy KC. Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy. Br J Clin Pract 1993; 47: 62–3

    PubMed  Google Scholar 

  95. Crews JR, Potts NLS, Schreiber J, et al. Hyponatraemia in a patient treated with sertraline [letter]. Am J Psychiatry 1993; 150: 1564

    PubMed  CAS  Google Scholar 

  96. Balestrieri G, Cerudelli B, Ciaccio S, et al. Hyponatraemia and seizure due to overdose of trazodone. BMJ 1992; 304: 686

    PubMed  CAS  Google Scholar 

  97. Baughan E, Jawad SSM. Effect of overdose of trazodone [letter]. BMJ 1992; 304: 1114

    PubMed  CAS  Google Scholar 

  98. Vincent JP, Bodak A. Syndrome ds’antidiurèse sous psychotrope. Une observation sous viloxazine. Ann Med Interne 1989; 140: 322–3

    Google Scholar 

  99. Giese AA, Leibenluft E, Green S, et al. Phenelzine-associated inappropriate ADH secretion [letter]. J Clin Psychopharmacol 1989; 9: 309–10

    PubMed  CAS  Google Scholar 

  100. Peterson JC, Pollack RW, Mahoney JJ, et al. Inappropriate antidiuretic hormone secondary to a monoamine oxidase inhibitor. JAMA 1978; 239: 1422–3

    PubMed  CAS  Google Scholar 

  101. Engel WR, Grau A. Inappropriate secretion of antidiuretic hormone associated with lorazepam. BMJ 1988; 297: 858

    PubMed  CAS  Google Scholar 

  102. Lahr MB. Hyponatremia due to carbamazepine therapy. Clin Pharmacol Ther 1985; 37: 693–6

    PubMed  CAS  Google Scholar 

  103. Palladino A. Hyponatraemia associated with carbamazepine therapy [letter]. Am J Psychiatry 1986; 143: 1190

    PubMed  CAS  Google Scholar 

  104. Juergens SM, Milliner DS, Lee ME. Carbamazepine and hyponatremia [letter]. Am J Psychiatry 1986; 143: 1328–9

    PubMed  CAS  Google Scholar 

  105. Uhde TW, Post RM. Effects of carbamazepine on serum electrolytes: clinical and theoretical implications. J Clin Psychopharmacol 1983; 3: 103–6

    PubMed  CAS  Google Scholar 

  106. Joffe RT, Post RM, Uhde TW. Effects of carbamazepine on serum electrolytes in affectively ill patients. Psychol Med 1986; 16: 331–5

    PubMed  CAS  Google Scholar 

  107. Yassa R, Iskandar H, Natase C, et al. Carbamazepine and hyponatremia in patients with affective disorder. Am J Psychiatry 1988; 145: 339–42

    PubMed  CAS  Google Scholar 

  108. Miyagawa CI. The pharmacological management of the syndrome of inappropriate secretion of antidiuretic hormone. DICP 1986; 20: 527–31

    CAS  Google Scholar 

  109. Kinzie BJ. Management of the syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharm 1987; 6: 625–33

    PubMed  CAS  Google Scholar 

  110. Seifert A, Schaefer K. Korrektur der schweren Hyponaträmie: langsam oder rasch? Dtsch Med Wschr 1991; 116: 952–7

    PubMed  CAS  Google Scholar 

  111. Ayus JC, Krotapalli RK, Arieff AI. Changing concepts in treatment of severe symptomatic hyponatremia: rapid correction and possible relation to central pontine myelinolysis. Am J Med 1985; 78: 897–902

    PubMed  CAS  Google Scholar 

  112. Sterns RH, Riggs JE, Schochet Jr SS. Osmotic demyelinisation syndrome following correction of hyponatraemia. N Engl J Med 1986; 314: 1535–42

    PubMed  CAS  Google Scholar 

  113. Höjer J. Management of symptomatic hyponatraemia: dependence on the duration of treatment. J Intern Med 1994; 235: 497–501

    PubMed  Google Scholar 

  114. Riggs AT, Dysken MW, Kim SW, et al. A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 1991; 32: 133–48

    PubMed  CAS  Google Scholar 

  115. Cluitmans FHM, Meinders AE. Management of severe hyponatremia: rapid or slow correction? Am J Med 1990; 88: 161–6

    PubMed  CAS  Google Scholar 

  116. Brösen K. Isozyme specific drug oxidation: genetic polymorphism and drug-drug interactions. Nord J Psychiatry 1993; 47 Suppl. 30: 21–6

    Google Scholar 

  117. Dahl M-L, Bertilsson L. Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics 1993; 3: 61–70

    PubMed  CAS  Google Scholar 

  118. de Caux G, Trimoulle S, Genette F, et al. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med 1980; 69: 99–106

    Google Scholar 

  119. Forrest Jr JN, Cox M, Hong C, et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173–7

    PubMed  Google Scholar 

  120. Cherhill DA, Stote RM, Birge JR, et al. Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. Ann Intern Med 1975; 83: 654–6

    Google Scholar 

  121. de Troyer A, Demanet J-C. Correction of antidiuresis by demeclocycline. N Engl J Med 1975; 293: 915–8

    PubMed  Google Scholar 

  122. Vieweg WVR, Wilkinson EC, David JJ, et al. The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatraemia, and polydipsia (PIP syndrome). Psychiatr Q 1988; 59: 62–8

    PubMed  CAS  Google Scholar 

  123. Dollery C. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1991: D25–8

    Google Scholar 

  124. White MG, Fetner CD. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 1975; 292: 390–2

    PubMed  CAS  Google Scholar 

  125. Finsterer U, Beyer A, Jensen U, et al. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH): treatment with lithium. Intensive Care Med 1982; 8: 223–9

    PubMed  CAS  Google Scholar 

  126. Vieweg V, Godleski L, Hundley P, et al. Antipsychotic drugs, lithium, carbamazepine, and abnormal diurnal weight gain in psychosis. Neuropsychopharmacology 1989; 2: 39–43

    PubMed  CAS  Google Scholar 

  127. Goldman MB. A rational approach to disorders of water balance in psychiatric patients. Hosp Community Psychiatry 1991; 42: 488–94

    PubMed  CAS  Google Scholar 

  128. Hamed M, Mitchell H, Clow DJ. Hyponatraemic convulsion associated with desmopressin and imipramine treatment. BMJ 1993; 306: 1169

    PubMed  CAS  Google Scholar 

  129. Miller MG. Tricyclics as a possible cause of hyponatremia in psychiatric patients [letter]. Am J Psychiatry 1989; 146: 807

    PubMed  CAS  Google Scholar 

  130. Doshi D, Borison R. Association of transient SIADH with sertraline [letter]. Am J Psychiatry 1994; 151: 779–80

    PubMed  CAS  Google Scholar 

  131. Bhargava R, Lewandowski BJ. Water intoxication: a complication of pelvic US in a patient with syndrome of inappropriate antidiuretic hormone secretion. Radiology 1991; 180: 723–4

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Norrland University Hospital, S-901 85, Umeå, Sweden

    Olav Spigset & Karin Hedenmalm

Authors
  1. Olav Spigset
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karin Hedenmalm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spigset, O., Hedenmalm, K. Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Psychotropic Drugs. Drug-Safety 12, 209–225 (1995). https://doi.org/10.2165/00002018-199512030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199512030-00006

Keywords

Search

Navigation